Tariff refunds are juicing corporate profits and GDP as more tailwinds converge to propel growth to a blistering 4.3% pace, top economist says ‘If your tariff was 0%, there’s no need to commit fraud’: The White House is sounding off on a $112 billion tariff-dodging scheme it made worse U.S. stocks fall after Iran says Strait of Hormuz will remain shut Trump is betting that the U.S. naval blockade choking Iran’s economy can achieve what bombs and missiles couldn’t as more oil sneaks out of the Gulf Gordan Chang – “China Is Broke – Rulers Are Desperate – Bad Things Are Going to Happen” American Airlines will stop upgrading elite flyers to business from coach on long domestic flights Does Africa still back Infantino as Fifa president? A billion SpaceX shares unlock Thursday. Wall Street isn’t worried: ‘You never bet against Elon.

Dennis Bastas

Dennis Bastas

Dennis Bastas (#1150)

Global Rank #1150
Country Rank #18
Country Australia

Dennis Bastas is listed among the world billionaires tracked by Iconic Billionaires.

  • $ 4 B
  • pharmaceuticals
  • Australia
  • M
  • 59 Years

Snapshot

Quick Facts

Global Rank #1,150
Country Rank #18
Net Worth $3.7B
Previous Worth $3.7B
Worth Change +$0.0B
Country Australia
Industry pharmaceuticals
Age 59 Years
Gender M
Worth As Of May 4, 2026
Last Refreshed 27 Jul 2026, 12:00 AM
Residence Victoria, Australia
World Billionaires List Australia Billionaires pharmaceuticals

Profile Data

Personal Stats

Age 59
Source Of Wealth pharmaceuticals, Self Made
Residence Victoria, Australia
Citizenship Australia
Education Bachelor of Engineering, Monash University
Net Worth Change +$0.0B +0.0% from previous worth
Previous Net Worth $3.7B
Current Net Worth $3.7B

Worth as of May 4, 2026

About Me

Dennis Bastas is chairman and group CEO of Australia-based diversified health and beauty company DBG Health. Bastas was born to Greek parents who migrated to Melbourne in 1960s. He began his career in logistics at retailing giant Coles Myer. In the early 2000s he founded Genepharm Australasia, which he later sold to Watson in 2012 for $252 million. In 2023, Bastas' DBG Health acquired three companies including Arrotex Pharmaceuticals, the country's largest pharmaceutical company by market share, for $671 million. In 2025, Bastas sold a stake in DBG Global Enterprises, the holding company of DBG Health, to global merchant bank BDT & MSD Partners for $1 billion, valuing the company at more than $4.7 billion.

Wealth Growth

Net Worth Growth Over Time

Tracking Dennis Bastas's net worth journey over the years, highlighting key growth phases and financial milestones.

© Iconic Billionaires